PCM
ISEE

Penserra Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Penserra Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,375
Closed -$38K – 1613
2021
Q3 		$38K Buy
2,375
+320
+16% +$3.48K ﹤0.01% 1133
2021
Q2 		$12K Buy
2,055
+20
+1% +$129 ﹤0.01% 1264
2021
Q1 		$12K Sell
2,035
-20
-1% -$121 ﹤0.01% 1018
2020
Q4 		$14K Buy
+2,055
New +$13.1K ﹤0.01% 893

Other funds holding ISEE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Penserra Capital Management's ISEE Position: Q4 2021 in Review

Penserra Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2021, closing a stake of 2,375 shares — an estimated $38K sold.

Penserra Capital Management first reported a position in ISEE in Q4 2020 and held it in 4 quarters. The position peaked at $38K in Q3 2021. 175 funds tracked by Wall St. Rank hold ISEE as of Q4 2021.

  • Penserra Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 2,375 IVERIC bio, Inc. Common Stock shares in Q4 2021, an estimated $38K.
  • Penserra Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
  • Penserra Capital Management's IVERIC bio, Inc. Common Stock position peaked at $38K in Q3 2021.
  • 175 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.